• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12B filed by CA Healthcare Acquisition Corp.

    10/12/21 4:59:58 PM ET
    $CAHC
    Finance
    Get the next $CAHC alert in real time by email
    15-12B 1 tm2128570-5_1512b.htm FORM 15-12B

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 15

     

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

    UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

    OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934.

    Commission File Number 001-39947

     

     

     CA Healthcare Acquisition Corp.

    (Exact name of registrant as specified in its charter)

     

     

    99 Summer Street Suite 200

    Boston, MA 02110

    (617) 314-3901

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

    Units, each consisting of one share of Class A Common Stock and one-half of one Warrant

    Class A Common Stock, par value $0.0001 per share

    Warrants, each exercisable for one share of Class A Common Stock for $11.50 per share

    (Title of each class of securities covered by this Form)

     

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

               
        Rule 12g-4(a)(1) x    
        Rule 12g-4(a)(2) ¨    
        Rule 12h-3(b)(1)(i) x    
        Rule 12h-3(b)(1)(ii) ¨    
        Rule 15d-6 ¨    
        Rule 15d-22(b) ¨    

     

     

    Approximate number of holders of record as of the certification or notice date: None.

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, CA Healthcare Acquisition Corp. has duly caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

     

     

     

     

     

     

    CA HEALTHCARE ACQUISITION CORP.

     

         
    Date: October 12, 2021 By: /s/ Larry J. Neiterman
      Name: Larry J. Neiterman
      Title: Chief Executive Officer

     

     

     

    Get the next $CAHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CAHC

    DatePrice TargetRatingAnalyst
    8/31/2021Buy
    Ladenburg Thalmann
    8/31/2021$14.75Buy
    Ladenburg Thalmann
    More analyst ratings

    $CAHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.

     LumiraDx's common shares will commence trading on September 29, 2021 on Nasdaq under the ticker symbol "LMDX" The Merger values LumiraDx at $3.0 billion (excluding the amounts raised by CAHC in its initial public offering) LumiraDx Limited ("LumiraDx"), a next-generation point of care ("POC") diagnostic testing company and CA Healthcare Acquisition Corp. ("CAHC"), a special purpose acquisition company traded on Nasdaq, today announced the completion of the previously announced merger. CAHC stockholders approved the merger (the "Merger") during a special meeting held today and final voting results will be disclosed by CAHC on a Form 8-K to be filed with the Securities and Exchange Comm

    9/28/21 6:55:00 PM ET
    $CAHC
    Finance

    CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination

    CA Healthcare's Board Recommends Stockholders Vote "FOR" the Business Combination and "FOR" all of the related proposals All stockholders of CA Healthcare as of September 1st, 2021 are encouraged to vote their shares in advance of the Special Meeting Stockholders who need assistance voting their shares should contact CA Healthcare's proxy solicitor, Morrow Sodali, at 203-658-9400 or via email at [email protected] CA Healthcare Acquisition Corp. (NASDAQ:CAHC) ("CA Healthcare"), a publicly traded special purpose acquisition company, and LumiraDx Limited ("LumiraDx"), a next-generation point of care diagnostics testing company, announced that the U.S. Securities and Exchange Commis

    9/7/21 4:28:00 PM ET
    $CAHC
    Finance

    LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics

    Revised transaction terms adjust LumiraDx's pro forma valuation for the combined group from $5 billion to $3 billion (excluding $115 million raised by CA Healthcare Acquisition Corp ("CAHC") in its initial public offering). Terms establish a more attractive entry point for investors, and a highly compelling investment thesis on an absolute and relative basis Factors considered in revising the valuation include: the recent market environment for publicly traded diagnostic companies, general decline in COVID-19 testing market, and feedback from CAHC's advisors and shareholders LumiraDx has a roadmap of 10 new test approvals over the next 24 months on its platform, including Troponin,

    8/20/21 8:00:00 AM ET
    $CAHC
    Finance

    $CAHC
    SEC Filings

    View All

    SEC Form 15-12B filed by CA Healthcare Acquisition Corp.

    15-12B - CA Healthcare Acquisition Corp. (0001832352) (Filer)

    10/12/21 4:59:58 PM ET
    $CAHC
    Finance

    CA Healthcare Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits

    8-K - CA Healthcare Acquisition Corp. (0001832352) (Filer)

    10/4/21 4:53:07 PM ET
    $CAHC
    Finance

    CA Healthcare Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - CA Healthcare Acquisition Corp. (0001832352) (Filer)

    9/28/21 8:57:54 PM ET
    $CAHC
    Finance

    $CAHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ladenburg Thalmann initiated coverage on CA Healthcare Acquisition

    Ladenburg Thalmann initiated coverage of CA Healthcare Acquisition with a rating of Buy

    8/31/21 8:05:58 AM ET
    $CAHC
    Finance

    Ladenburg Thalmann initiated coverage on Compost America Holding with a new price target

    Ladenburg Thalmann initiated coverage of Compost America Holding with a rating of Buy and set a new price target of $14.75

    8/31/21 7:18:31 AM ET
    $CAHC
    Finance

    $CAHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CA Healthcare Acquisition Corp.

    SC 13G - CA Healthcare Acquisition Corp. (0001832352) (Subject)

    9/24/21 4:43:05 PM ET
    $CAHC
    Finance

    SEC Form SC 13G filed by CA Healthcare Acquisition Corp.

    SC 13G - CA Healthcare Acquisition Corp. (0001832352) (Subject)

    4/14/21 4:22:04 PM ET
    $CAHC
    Finance